Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEAT 3% nasal spray for uncomplicated viral rhinitis
2008-005442-23Phase 3Completed
- Sponsor
- Leyh Pharma GmbH
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in viral rhinitis and nasopharyngitis comparing SEAT 3% nasal spray with Placebo (2 arms). Primary endpoint: Improvement from baseline of viral rhinitis symptom score. Started Feb 2009; status: completed.
02
Drugs
silver protein acetyl tannate
03
Conditions
viral rhinitisnasopharyngitis
Beyond the preview
Go deeper on 2008-005442-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005442-23.